DiaMedica Therapeutics Inc.
DMAC
$3.53
-$0.01-0.28%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -24.44M | -21.71M | -19.90M | -19.26M | -19.38M |
| Total Depreciation and Amortization | 39.00K | 36.00K | 34.00K | 31.00K | 30.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 817.00K | 646.00K | 446.00K | 473.00K | 530.00K |
| Change in Net Operating Assets | 1.51M | 1.57M | -359.00K | -1.54M | 93.00K |
| Cash from Operations | -22.08M | -19.45M | -19.78M | -20.29M | -18.73M |
| Capital Expenditure | -25.00K | -21.00K | -22.00K | -26.00K | -24.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 8.59M | 9.50M | 16.29M | -16.57M | -18.28M |
| Cash from Investing | 8.56M | 9.48M | 16.26M | -16.60M | -18.30M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -9.00K | -7.00K | -6.00K | -6.00K | -6.00K |
| Issuance of Common Stock | 12.00M | 11.88M | 11.75M | 36.85M | 36.85M |
| Repurchase of Common Stock | -- | -- | -4.00K | -4.00K | -4.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 11.99M | 11.87M | 11.74M | 36.84M | 36.84M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.52M | 1.90M | 8.23M | -50.00K | -185.00K |